About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 19,080 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1941-1960 of 19,080 trials

RecruitingVertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).NCT03999983·Jacksonville, Florida and 9 others CompletedThe PEERLESS StudyA prospective, multicenter, randomized controlled trial of the FlowTriever System compared to Catheter-Directed Thrombolysis (CDT) for use in the treatment of acute pulmonary…NCT05111613·Loma Linda, California and 59 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

Enrolling by invitationImage-guided Cochlear Implant Programming (IGCIP)Cochlear implants are surgically implanted devices which restore the ability to hear to the hearing impaired.NCT03306082·Nashville, Tennessee

CompletedA Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic DermatitisThe purpose of this study is to evaluate the safety and efficacy of lebrikizumab compared with placebo in participants with moderate-to-severe atopic dermatitis.NCT03443024·Scottsdale, Arizona and 57 others

CompletedDose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Gadavist when used for taking images of the brain and spine.NCT00862459·Sacramento, California and 26 others

WithdrawnReduced Ventilator-Free Days and Bacterial Colonization of Sub-Glottic SecretionsVentilator associated pneumonia (VAP) is common problem among ICU patients and major source of infection among patients receiving mechanical ventilation.NCT02311296·Chattanooga, Tennessee

CompletedGemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003546·Birmingham, Alabama and 47 others

CompletedActos Now for Prevention of Diabetes (ACT NOW)The purpose of this study is to examine whether pioglitazone versus placebo can reduce the conversion rate of impaired glucose tolerance (IGT) to type 2 diabetes mellitusNCT00220961·Phoenix, Arizona and 7 others

CompletedA Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)This Phase III study was designed to evaluate the efficacy and safety of KX2-391 Ointment 1% in adult participants when applied to an area of skin containing 4-8 stable…NCT03285490·Phoenix, Arizona and 29 others

CompletedCC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple MyelomaRandomized subjects will receive CC-5013 plus high-dose dexamethasone or placebo appearing identical to CC-5013 plus high-dose dexamethasone in 4-week cycles.NCT00056160·Hoover, Alabama and 48 others

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

CompletedAn Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure ProphylaxisApproximately 200 HIV-uninfected young men who have sex with men (YMSM) at high risk of acquiring HIV infection, ages 18-22 years, inclusive, will be recruited across all…NCT01772823·Los Angeles, California and 11 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05736861·Gilbert, Arizona and 86 others

TerminatedSafety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)The purpose of this study is to characterize the safety and tolerability of ixazomib when administered as multiple oral doses at escalating dose levels in participants with lupus…NCT02176486·La Jolla, California and 34 others

Active not recruitingA Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung CancerTo confirm a recommended Phase 2 dose (RP2D) of FF-10832 (Gemcitabine Liposome Injection) given intravenously Day 1 of a 21-day cycle, in combination with 200 mg pembrolizumab…NCT05318573·Long Beach, California and 22 others

CompletedPhase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid TumorsTo evaluate the safety and tolerability of Oprozomib in patients with advanced refractory or recurrent solid tumors including determination of its Dose Limiting Toxicity (DLT) and…NCT01129349·Scottsdale, Arizona and 2 others

RecruitingNeoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast CancersThis phase II trial tests how well neratinib prior to the primary treatment (neoadjuvant) works in treating patients with stage I-III HER2 mutated lobular breast cancers.NCT05919108·Atlanta, Georgia and 4 others

CompletedBortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal CancerRATIONALE: Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00280176·Chapel Hill, North Carolina and 1 other

CompletedA Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise AloneThe main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes and inadequate glycemic control…NCT05971940·Sheffield, Alabama and 88 others

Active not recruitingEvaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid HemorrhageIn this project we are collecting cerebrospinal fluid and blood from patients at Vanderbilt Medical Center who have a subarachnoid hemorrhage which has followed the rupture of a…NCT00593268·Nashville, Tennessee

PreviousPage 98 of 954Next

Diabetes

in Tennessee

Heart Diseasein Tennessee